Inari Medical to Present at the 43rd Annual Canaccord Growth Conference
26 Julho 2023 - 5:01PM
Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device
company with a mission to treat and transform the lives of patients
suffering from venous and other diseases, announced today that its
management team will present at the 43rd Annual Canaccord Growth
Conference on Wednesday, August 9, 2023 at 4:00 p.m. Eastern Time
at the InterContinental Boston Hotel in Boston, MA.
A live audio webcast and replay of the presentation
may be accessed for 30 days on the “Investor Relations” section of
the company’s website at: https://www.inarimedical.com/.
About Inari Medical, Inc.Patients
first. No small plans. Take care of each other. These are the
guiding principles that form the ethos of Inari Medical. We are
committed to improving lives in extraordinary ways by creating
innovative solutions for both unmet and underrecognized health
needs. In addition to our purpose-built products, we leverage our
capabilities in education, clinical research, and program
development to improve patient outcomes. We are passionate about
our mission to establish our treatments as the standard of care for
venous thromboembolism and beyond. We are just getting started.
Investor Contact:John Hsu, CFAVP,
Investor Relations949-658-3889IR@inarimedical.com
Inari Medical (NASDAQ:NARI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Inari Medical (NASDAQ:NARI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024